Register for the 2023 SOSV Climate Tech Summit on Sept. 26-27.


Developing a drug-free cancer therapy based on nutrient deprivation


Grace Yang

COO & Co-Founder

Jimmy Wang

CTO & Co-Founder

Xiyan Li

CEO & Co-Founder

Company details

Filtricine, Inc. is a pre-clinical-stage therapeutic company. For cancer patients who want effective, safe, and long-lasting treatment, Filtricine is developing a drug-free cancer therapy based on nutrient deprivation. By precisely taking away the nutrients that are necessary only for cancer cells, the therapy kills only the cancer—not the patient.

Get In Touch with Filtricine

Please tell us a little bit about yourself and why you'd like to get connected. Filtricine + SOSV will follow up with you via email.

* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.